Oxford Covid-19 vaccine produces immune response across all ages - AstraZeneca
26th Oct 2020 09:25
(Sharecast News) - AstraZeneca said on Monday that the Covid-10 vaccine that is being developed by the University of Oxford triggers a similar immune response in people across different age groups, including the elderly.
Read moreAstraZeneca Covid-19 vaccine clinical trial readout may arrive in mid-November, Jefferies says
23rd Oct 2020 11:12
(Sharecast News) - Analysts at Jefferies estimated that an initial read-out on AstraZeneca and Oxford University's ongoing late-stage trial of its Covid-19 vaccine might ready towards the middle of November.
Read moreModerna's Covid-19 vaccine may be ready for use by December
20th Oct 2020 14:01
(Sharecast News) - Moderna's Covid-19 vaccine candidate could be ready for use in December, the company's boss said.
Read moreAstraZeneca gets FDA nod for Tagrisso in certain lung cancers
20th Oct 2020 08:12
(Sharecast News) - AstraZeneca announced on Tuesday that 'Tagrisso', or osimertinib, has received acceptance for its supplemental New Drug Application (sNDA), and has also been granted Priority Review in the United States, for the adjuvant treatment of patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC), after complete tumour resection with curative intent.
Read moreMonday broker round-up
19th Oct 2020 13:30
(Sharecast News) - Intercontinental Hotels Group: Peel Hunt downgrades to hold with a target price of 4,300p.
Read moreAstraZeneca COPD drug wins EU marketing approval
19th Oct 2020 07:02
(Sharecast News) - AstraZeneca said its Trixeo Aerosphere had been given marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD).
Read moreAstraZeneca advances Covid-19 antibodies with US funding
12th Oct 2020 07:29
(Sharecast News) - AstraZeneca announced on Monday that its long-acting antibody (LAAB) combination for Covid-19, AZD7442, would advance into two phase 3 clinical trials in more than 6,000 participants both in and outside the US in the coming weeks.
Read moreEli Lilly's Covid-19 antibody treatment shows promise, company says
8th Oct 2020 11:42
(Sharecast News) - US drug giant Eli Lilly's monoclonal antibody treatment is effective in reducing levels of the novel coronavirus in patients and appears to be able to keep them from having to go go the emergency room or hospital, the company said.
Read moreAstraZeneca gets another FDA nod for Farxiga
2nd Oct 2020 07:28
(Sharecast News) - AstraZeneca announced on Friday that 'Farxiga' or dapagliflozin, has been granted Breakthrough Therapy Designation by the US Food and Drug Administration (FDA) for patients with chronic kidney disease, with and without type-2 diabetes.
Read moreModerna Covid-19 vaccine may be ready for full-scale use by early Q2 2020
1st Oct 2020 09:04
(Sharecast News) - Moderna's Covid-19 vaccine candidate will not be ready by the 3 November presidential elections in the US, but it could be by the end of that month.
Read moreFDA expands probe into AstraZeneca Covid-19 vaccine candidate
1st Oct 2020 07:30
(Sharecast News) - America's main health regulator, the Food and Drug Administration, has widened its investigation into the adverse event related to one patient in AstraZeneca's ongoing phase three clinical trial of its Covid-19 vaccine candidate, Reuters reported, which remains on hold in the States.
Read moreLondon pre-open: Stocks set for higher start on US stimulus hopes
1st Oct 2020 07:28
(Sharecast News) - Futures are pointing to a positive start to the month and to the fourth quarter for stocks in London, buoyed by news overnight that US lawmakers were narrowing their differences over the proposed size of a fourth government stimulus package.
Read moreCovid-19 deaths reach 1m, WHO claims virus still suppressible
29th Sep 2020 11:23
(Sharecast News) - The World Health Organization (WHO) said on Tuesday that the number of global deaths from Covid-19 had reached 1m but that the virus was still suppressible.
Read moreInovio shares crash after FDA places partial hold on Covid-19 trial
28th Sep 2020 13:30
(Sharecast News) - Inovio's phase 2/3 trial of its Covid-19 vaccine candidate was put on partial hold by the US Food and Drug Administration, sending the shares crashing.
Read moreAstraZeneca 'under fire' for vaccine safety, NYT says
21st Sep 2020 12:48
(Sharecast News) - AstraZeneca disclosed details of its Covid-19 vaccine trials at the weekend to address criticism around pharmaceutical companies' transparency and avoid the risk of engendering skepticism in the public about the safety of any potential vaccines.
Read more